ArticleFrontiers in nephrology2022

Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia.

Xiaoe You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.